Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin
- PMID: 17242258
- DOI: 10.2214/AJR.05.2079
Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin
Abstract
Objective: To identify the determinants of tumor progression, we examined the ablation zones and patterns of local progression of small single primary hepatocellular carcinomas after radiofrequency ablation.
Materials and methods: Eighty-five patients with single primary hepatocellular carcinoma less than 3 cm in diameter underwent complete tumor ablation. Clinical and biochemical features, tumor characteristics, tumor location within 5 mm from intrahepatic vessels, needle biopsy before treatment, and presence of ablative margin of 5 mm or more were statistically analyzed as determinants of local tumor progression. The Kaplan-Meier method and a Cox model were used for the analyses. Patterns of local tumor progression were examined by image analysis.
Results: During a median observation period of 30.3 months, 14 (16.5%) of the 85 patients had local tumor progression. The results of the log-rank test showed that the presence of vessels contiguous with the tumor (p = 0.0292) and the absence of an ablative margin of at least 5 mm (p = 0.019) significantly correlated with local tumor progression. Cox regression analysis showed that the absence of an ablative margin of at least 5 mm was an independent factor (p = 0.04). The most common pattern of local tumor progression was a single viable outgrowth from the side of the ablated area when the ablative margin was less than 5 mm. Multiple viable outgrowths were observed in one case despite the presence of an ablative margin greater than 5 mm.
Conclusion: An ablation zone with an ablative margin of 5 mm or greater was the most important factor for local control of hepatocellular carcinoma.
Similar articles
-
Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.Jpn J Clin Oncol. 2007 Sep;37(9):658-72. doi: 10.1093/jjco/hym086. Epub 2007 Aug 31. Jpn J Clin Oncol. 2007. PMID: 17766723
-
Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.Eur J Radiol. 2006 Sep;59(3):432-41. doi: 10.1016/j.ejrad.2006.03.007. Epub 2006 May 9. Eur J Radiol. 2006. PMID: 16690240
-
Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.Cancer. 2003 Mar 1;97(5):1253-62. doi: 10.1002/cncr.11168. Cancer. 2003. PMID: 12599233
-
Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.J Hepatobiliary Pancreat Surg. 2008;15(6):589-95. doi: 10.1007/s00534-007-1288-4. Epub 2008 Nov 7. J Hepatobiliary Pancreat Surg. 2008. PMID: 18987928 Review.
-
Post-treatment MRI findings of hepatocellular carcinoma.Diagn Interv Radiol. 2009 Jun;15(2):111-20. Diagn Interv Radiol. 2009. PMID: 19517381 Review.
Cited by
-
Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols.Exp Ther Med. 2012 Dec;4(6):959-961. doi: 10.3892/etm.2012.706. Epub 2012 Sep 13. Exp Ther Med. 2012. PMID: 23226755 Free PMC article.
-
Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy.Front Immunol. 2022 Oct 28;13:1019772. doi: 10.3389/fimmu.2022.1019772. eCollection 2022. Front Immunol. 2022. PMID: 36389724 Free PMC article. Clinical Trial.
-
Radiofrequency Ablation Using a Separable Clustered Electrode for the Treatment of Hepatocellular Carcinomas: A Randomized Controlled Trial of a Dual-Switching Monopolar Mode Versus a Single-Switching Monopolar Mode.Korean J Radiol. 2021 Feb;22(2):179-188. doi: 10.3348/kjr.2020.0134. Epub 2020 Jul 22. Korean J Radiol. 2021. PMID: 32729269 Free PMC article. Clinical Trial.
-
Radiofrequency ablation during continuous saline infusion can extend ablation margins.World J Gastroenterol. 2013 Feb 28;19(8):1278-82. doi: 10.3748/wjg.v19.i8.1278. World J Gastroenterol. 2013. PMID: 23483097 Free PMC article.
-
Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization.Korean J Intern Med. 2019 Nov;34(6):1223-1232. doi: 10.3904/kjim.2018.058. Epub 2018 Oct 26. Korean J Intern Med. 2019. PMID: 30360019 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical